The trademark application XYRE was filed by Fertin Pharma A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on August 8, 2023, and it was registered by office on November 15, 2023 without any oppositions.
The application was filed in Danish (English was selected as the second language).